These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7551643)

  • 1. Swarming and pathogenicity of Proteus mirabilis in the urinary tract.
    Mobley HL; Belas R
    Trends Microbiol; 1995 Jul; 3(7):280-4. PubMed ID: 7551643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
    Zhao H; Li X; Johnson DE; Mobley HLT
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteus mirabilis and Urinary Tract Infections.
    Schaffer JN; Pearson MM
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
    Norsworthy AN; Pearson MM
    Trends Microbiol; 2017 Apr; 25(4):304-315. PubMed ID: 28017513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.
    Armbruster CE; Mobley HL
    Nat Rev Microbiol; 2012 Nov; 10(11):743-54. PubMed ID: 23042564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Proteus mirabilis urinary tract infection.
    Coker C; Poore CA; Li X; Mobley HL
    Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection.
    Mobley HL; Belas R; Lockatell V; Chippendale G; Trifillis AL; Johnson DE; Warren JW
    Infect Immun; 1996 Dec; 64(12):5332-40. PubMed ID: 8945585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.
    Pearson MM; Mobley HLT
    J Med Microbiol; 2007 Oct; 56(Pt 10):1277-1283. PubMed ID: 17893161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Legnani-Fajardo C; Maskell DJ
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):137-43. PubMed ID: 11024353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.